This webinar will be hosted live and available on-demand

Thursday, September 28, 2023 
9:30 AM Eastern Time 

Molecular research advances expand the sensitivity and specificity of cancer detection, monitoring, and characterization. In the past two decades, researchers and clinicians transformed precision medicine to develop safer and more effective cancer treatments based on the unique genetic and molecular makeup of each tumor. 

In this webinar brought to you by Bio-Rad, Genevieve Boland and Francesca Orzan will present their latest research applying molecular analyses and technical breakthroughs to move novel assays closer to the clinic.

Topics to be covered 

  • Plasma biomarkers for metastatic melanoma
  • Cerebrospinal fluid liquid biopsies for glioma diagnosis
Genevieve Boland, MD, PhD

 Genevieve Boland, MD, PhD
 Vice Chair of Research, Department of Surgery
 Section Head, Melanoma/Sarcoma Surgery
 Surgical Director, Termeer Center for Targeted Therapies
 Director, Surgical Oncology Research Laboratories
 MGH Research Scholar
 Massachusetts General Hospital
 Associate Professor of Surgery, Harvard Medical School

Francesca Orzan, PhD

 Francesca Orzan, PhD
 Research Assistant
 Laboratory of Cancer Stem Cell Research
 Candiolo Cancer Institute - FPO, IRCCS 
 Department of Oncology
 University of Torino Medical School


Sponsored by